CAM
RLAY icon

Congress Asset Management’s Relay Therapeutics RLAY Stock Holding History

Congress Asset Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.1M Buy
779,544
+153,403
+24% +$2.94M 0.09% 188
2026
Q2 		$11.7M Buy
626,141
+7,203
+1% +$105K 0.07% 207
2026
Q1 		$6.16M Buy
618,938
+204,771
+49% +$1.83M 0.04% 240
2025
Q4 		$3.5M Buy
414,167
+5,325
+1% +$38K 0.02% 251
2025
Q3 		$2.13M Buy
408,842
+252,142
+161% +$961K 0.01% 278
2025
Q2 		$542K Buy
156,700
+498
+0.3% +$1.48K ﹤0.01% 339
2025
Q1 		$409K Sell
156,202
-1,283
-0.8% -$5.03K ﹤0.01% 334
2024
Q4 		$649K Buy
157,485
+11,061
+8% +$60.2K ﹤0.01% 335
2024
Q3 		$1.04M Sell
146,424
-1,186
-0.8% -$8.86K 0.01% 298
2024
Q2 		$962K Sell
147,610
-1,472
-1% -$10.1K 0.01% 299
2024
Q1 		$1.24M Buy
149,082
+2,108
+1% +$20.6K 0.01% 292
2023
Q4 		$1.62M Buy
146,974
+540
+0.4% +$4.56K 0.01% 302
2023
Q3 		$1.23M Buy
146,434
+207
+0.1% +$2.23K 0.01% 298
2023
Q2 		$1.84M Buy
+146,227
New +$1.82M 0.02% 287

Other funds holding RLAY

VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Congress Asset Management's RLAY Position: Q3 2026 in Review

Congress Asset Management increased its Relay Therapeutics (RLAY) stake by 24% in Q3 2026, buying an estimated $2.94M and bringing the position to 779,544 shares worth $14.1M. The position accounts for 0.09% of the portfolio, ranked #188.

Congress Asset Management first reported a position in RLAY in Q2 2023 and has held it in 14 quarters since. 6 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

  • Congress Asset Management held 779,544 shares of Relay Therapeutics worth $14.1M as of Q3 2026.
  • Congress Asset Management bought 153,403 Relay Therapeutics shares in Q3 2026, an estimated $2.94M.
  • Relay Therapeutics made up 0.09% of Congress Asset Management's portfolio in Q3 2026, its #188 holding.
  • Congress Asset Management first reported a position in Relay Therapeutics in Q2 2023 and has held it in 14 quarters since.
  • 6 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on Congress Asset Management's 13F filing for Q3 2026, filed 6 Oct 2026.